Related Experiment Videos
Antisense drug discovery: can cell-free screens speed the process?
1Department of Medicine, The Mount Sinai School of Medicine, New York, New York 10029, USA.
Antisense & Nucleic Acid Drug Development
|July 21, 1998
Summary
Identifying effective antisense drug targets is challenging. Current cell-free screening methods, like RNase H-based assays, aim to streamline this process but face challenges with naked RNA surrogates.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Antisense drugs require specific conditions to function, including target RNA colocalization, favorable structure, and complementary binding sites.
- Identifying vulnerable target sites for antisense compounds is difficult due to undefined properties, often relying on laborious trial-and-error screening.
Purpose of the Study:
- To review data from RNase H-based screens for identifying antisense drug targets.
- To summarize challenges associated with cell-free screening methods using naked RNAs as surrogates for intracellular targets.
Main Methods:
- Review of existing data from RNase H-based screening studies.
- Analysis of challenges in cell-free screening for antisense target identification.
Main Results:
- RNase H-based screens assume ideal target sites have unique properties detectable in cell-free assays.
- The effectiveness of cell-free screening methods for predicting in vivo antisense drug efficacy remains uncertain.
Conclusions:
- Cell-free screening methods, while promising for reducing compound testing, face challenges related to the use of naked RNAs.
- Further research is needed to validate the effectiveness of these methods in identifying optimal antisense drug targets.